Abstract
Although new treatments can prolong progression-free and overall survival in patients with renal cell carcinoma (RCC), the cure rate remains low and surgical resection of the primary tumor and metastases are still the most important treatment options to eliminate RCC or achieve long-term progression-free survival.
MeSH terms
-
Antineoplastic Agents / therapeutic use
-
Carcinoma, Renal Cell / drug therapy
-
Carcinoma, Renal Cell / mortality
-
Carcinoma, Renal Cell / surgery*
-
Humans
-
Kidney Neoplasms / drug therapy
-
Kidney Neoplasms / mortality
-
Kidney Neoplasms / surgery*
-
Lung Neoplasms / drug therapy
-
Lung Neoplasms / secondary
-
Lung Neoplasms / surgery
-
Neoplasm Metastasis
-
Survival Rate / trends